Balyasny Asset Management Portfolio holdings
AUM
$44B
1-Year Return
17.37%
This Quarter Return
-0.7%
1 Year Return
+17.37%
3 Year Return
+72.12%
5 Year Return
+152.69%
10 Year Return
+378.29%
AUM
$39.9B
AUM Growth
-$3.06B
(-7.1%)
Cap. Flow
-$2.28B
Cap. Flow
% of AUM
-5.71%
Top 10 Holdings %
Top 10 Hldgs %
11.13%
Holding
2,532
New
591
Increased
715
Reduced
610
Closed
508
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$484M |
| 2 |
Mastercard
MA
|
+$407M |
| 3 |
Charles Schwab
SCHW
|
+$400M |
| 4 |
SPDR S&P 500 ETF Trust
SPY
|
+$287M |
| 5 |
Intuit
INTU
|
+$283M |
Top Sells
| 1 |
Arthur J. Gallagher & Co
AJG
|
+$455M |
| 2 |
Coca-Cola
KO
|
+$423M |
| 3 |
Starbucks
SBUX
|
+$330M |
| 4 |
Salesforce
CRM
|
+$303M |
| 5 |
PNC Financial Services
PNC
|
+$274M |
Sector Composition
| 1 | Technology | 15.69% |
| 2 | Financials | 14.96% |
| 3 | Consumer Discretionary | 13.59% |
| 4 | Industrials | 10.73% |
| 5 | Healthcare | 10.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1501
AnaptysBio
ANAB
$649M
| $596K | ﹤0.01% |
+32,074
| New | +$596K |
|
1502
Pearson
PSO
$9.25B
| $596K | ﹤0.01% |
37,197
+25,268
| +212% | +$405K |
|
1503
Sana Biotechnology
SANA
$875M
| $595K | ﹤0.01% |
+354,238
| New | +$595K |
|
1504
The GEO Group
GEO
$3.26B
| $589K | ﹤0.01% |
20,170
-759,305
| -97% | -$22.2M |
|
1505
Worthington Steel
WS
$1.7B
| $587K | ﹤0.01% |
+23,172
| New | +$587K |
|
1506
Hallador Energy
HNRG
$736M
| $587K | ﹤0.01% |
47,768
-24,953
| -34% | -$306K |
|
1507
Raymond James Financial
RJF
$34.1B
| $584K | ﹤0.01% |
4,205
+2,041
| +94% | +$284K |
|
1508
Carnival PLC
CUK
$38.7B
| $581K | ﹤0.01% |
+33,158
| New | +$581K |
|
|
BRSL
1509
Brightstar Lottery PLC
BRSL
$3.18B
| $581K | ﹤0.01% |
35,710
-1,056,333
| -97% | -$17.2M |
|
1510
Boston Beer
SAM
$2.4B
| $580K | ﹤0.01% |
2,429
-13,326
| -85% | -$3.18M |
|
1511
McKesson
MCK
$89.5B
| $580K | ﹤0.01% |
862
-49,156
| -98% | -$33.1M |
|
1512
Corcept Therapeutics
CORT
$7.83B
| $578K | ﹤0.01% |
5,064
-4,416
| -47% | -$504K |
|
1513
Nektar Therapeutics
NKTR
$898M
| $578K | ﹤0.01% |
+56,674
| New | +$578K |
|
1514
TTM Technologies
TTMI
$4.99B
| $575K | ﹤0.01% |
28,041
-77,527
| -73% | -$1.59M |
|
1515
QCR Holdings
QCRH
$1.32B
| $574K | ﹤0.01% |
+8,050
| New | +$574K |
|
1516
Brown & Brown
BRO
$31.1B
| $572K | ﹤0.01% |
4,595
-682,500
| -99% | -$84.9M |
|
1517
Select Water Solutions
WTTR
$954M
| $572K | ﹤0.01% |
+54,434
| New | +$572K |
|
1518
Xometry
XMTR
$2.57B
| $569K | ﹤0.01% |
+22,847
| New | +$569K |
|
1519
Kforce
KFRC
$583M
| $568K | ﹤0.01% |
11,614
-29,199
| -72% | -$1.43M |
|
1520
Viavi Solutions
VIAV
$2.74B
| $566K | ﹤0.01% |
50,612
-3,924
| -7% | -$43.9K |
|
1521
US Bancorp
USB
$76.8B
| $562K | ﹤0.01% |
13,306
+7,602
| +133% | +$321K |
|
1522
Treace Medical Concepts
TMCI
$470M
| $560K | ﹤0.01% |
66,748
+55,025
| +469% | +$462K |
|
1523
LPL Financial
LPLA
$27.8B
| $560K | ﹤0.01% |
1,711
-469,777
| -100% | -$154M |
|
1524
Repay Holdings
RPAY
$509M
| $559K | ﹤0.01% |
100,388
+25,291
| +34% | +$141K |
|
1525
NCR Atleos
NATL
$2.88B
| $557K | ﹤0.01% |
+21,121
| New | +$557K |
|